Our Partners

Illumina is an applied genomics technology company making genomics widespread. They create leading-edge technology that enables clinicians and researchers to not only understand the genome but also fully tap its power.

As a company, they have both a clinical and research focus.  This includes cancer, microbiology, agrigenomics, complex disease, cellular and molecular biology, reproductive health, genetic and rare disease, and oncology. 

SomaLogic seeks to transform healthcare by focusing on understanding and acting on changes in proteins, the most relevant molecular underpinning of disease and health. Thanks to early adopters of our technology and far-sighted collaborators, we now have a large — and rapidly growing — database of protein-based insights across many human diseases and conditions.

We collaborate globally with innovative public and private organizations to continually discover new and clinically meaningful insights for drug discovery and development, increased biological knowledge, and health and disease management.

We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 4,100 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more. Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

As a PacBio Certified Service Provider, MGI continues to work with the latest technology, a Sequel II System. The Single Molecule, Real-Time (SMRT) Sequencing is the core technology for powering this long-read technology. 

The PacBio Certified Service Provider Program is a global network of validated sequencing service labs that provides access to Single Molecule, Real-Time (SMRT) Sequencing. To achieve this certification, each provider must undergo a rigorous process that includes the most up-to-date training on PacBio sample processing and data analysis workflows. From these processes, our service providers are equipped to deliver the highest quality services for our advanced sequencing technology.

Whether your research strives to improve human health directly or seeks a deeper understanding of who we are and where we came from Integrated DNA Technologies (IDT) will supply you with quality reagents and an expanding range of technologies. The Genome Technology Access Center at McDonnell Genome Institute at Washington University in St. Louis is ready to help you plan and execute your personalized project. 

GTAC@MGI has established itself as a world leader in its comprehensive range of genomic services.  GTAC@MGI and IDT are aligning through their commitment to collaborate and break down research barriers for this generation of life scientists, and the next. As the inaugural partner for IDT’s Align™ Preferred Sequencing Provider program, GTAC@MGI welcomes the opportunity to bring the best science to our research and service colleagues. To learn more about the IDT Align™ Preferred Sequencing Program visit IDT.  For sequencing or other genomic services please connect with GTAC@MGI.

An AI venture providing fundamentally different augmented intelligence software across a variety of healthcare applications, including life sciences, drug discovery, payment integrity and medical claims.

Developed by computational biologists at the Genome Technology Access Center (GTAC) at Washington University in St. Louis with funding from Kingdom Capital, the unique analytical model has trained for multiple years using data at GTAC across hundreds of labs and all types of biology. PercayAI exclusively licensed the software in 2019.